About
Jacob Cedergreen.
Two decades inside the largest PBMs and health services organizations in the country (Express Scripts, Cigna / Evernorth, Elevance / CarelonRx) running the pricing, the underwriting, the rebate liability, the integrations, and the P&Ls that define modern pharmacy economics.
Now independent, building PBM Advantage out of St. Louis, focused on the operators, plans, systems, TPAs, and employers who need PBM economics to work to their advantage.
Highlights
$50B
ARR pricing strategy, Cigna/Evernorth
$20B
Annual rebate liability operations
Career
The seat behind the work.
2026 →
Principal Consultant, PBM Advantage
$35B+
CarelonRx revenue as CFO
$15B
Home delivery pharmacy P&L (GM)
$4.7B
WellPoint PBM acquisition lead analyst
3
U.S. patents in pharmacy pricing & networks
2023–25
CFO, CarelonRx · Elevance Health
$35B+ revenue, 360+ team, 3 acquisitions
2022–23
SVP, Business Development · Transcarent
Digital health, telemedicine integration
2019–22
VP, Evernorth Finance & Strategy · Cigna
$50B ARR pricing, $20B rebate ops, federal transparency SME
2026-19
VP, Governance & Strategy · Express Scripts
$2B+ annual sales EBITDA; underwriting, pricing, IT model owner
2012-16
VP, Health Plan Division CFO Express Scripts
$25B revenue P&L
2010-12
VP / GM, Home Delivery Pharmacy Express Scripts
$15B P&L; Medco integration; Walgreens network response
2003-12
Director, Pricing, Underwriting & Analytics Express Scripts
Lead analytics on $4.7B WellPoint PBM acquisition
U.S. Patents
Pricing, Technology & Operating IP, on the books.
US 10,373,255 · 2019 Pharmacy Provider Networks
US 10,235,729 · 2019 Preferred Pharmacy Designation
US 8,335,695 · 2012 Pharmaceutical Pricing Method
Credentials
Missouri Insurance Agent License (Life, Accident & Health)
Executive Certificate, Marketing — Northwestern Kellogg
MBA — University of Missouri
MHA — University of Missouri
BS — University of Illinois
Board service
National Board Member — Oasis Lifelong Adventure (2017–present)
Board Member — Crown Center for Senior Living (2016–2019)